aminoimidazole carboxamide has been researched along with resveratrol in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 17 (85.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dasgupta, B; Milbrandt, J | 1 |
| Yang, SJ; Yu, L | 1 |
| Hsu, MH; Johnson, EF; Lasker, JM; Savas, U | 1 |
| Ho-Wo-Cheong, D; Kodiha, M; Stochaj, U | 1 |
| Ishida, S; Kubota, S; Kurihara, T; Miyake, S; Noda, K; Ozawa, Y; Sasaki, M; Tsubota, K; Yuki, K | 1 |
| Haneda, M; Iwasaki, K; Kobayashi, T; Kuzuya, T; Miwa, Y; Ogawa, H; Onishi, A | 1 |
| Komen, JC; Thorburn, DR | 1 |
| Hofer, A; Kladt, N; Lellek, V; Noe, N; Schauß, A; Tischner, C; Wenz, T | 1 |
| Kodiha, M; Salimi, A; Stochaj, U; Wang, YM | 1 |
| Han, Y; Jamangulova, N; Jiang, C; Liu, W; Song, X; Tang, J; Wang, C; Wu, P; Wu, X; Zhang, G | 1 |
| Huang, F; Kou, J; Li, J; Liu, B; Liu, K; Qi, L; Sun, Y; Wang, M; Xiao, N | 1 |
| Hu, XG; Liu, B; Ma, LJ; Qi, Y; Shang, JY; Sun, BB; Zhang, GJ | 1 |
| Amato, S; Gilbert, J; Man, HY; Wang, G | 1 |
| Beauloye, C; Bertrand, L; Daskalopoulos, EP; Dufeys, C; Horman, S | 1 |
| Cao, Y; Li, M; Li, MZ; Liu, BJ; Shi, FX; Sun, DS; Tian, Q; Wang, JZ; Wang, L; Xu, WQ; Zhou, XW | 1 |
| Calabuig-Navarro, V; Haghiac, M; Landau, D; Minium, J; O'Tierney-Ginn, P; Skomorovska-Prokvolit, Y | 1 |
| Al-Rewashdy, A; Bélanger, G; Jasmin, BJ; Ravel-Chapuis, A | 1 |
| Baker, BA; Booth, FW; Childs, TE; Gladden, LB; Kavazis, AN; Mumford, PW; Osburn, SC; Parry, HA; Roberson, PA; Roberts, MD; Romero, MA; Schwartz, TS; Toedebusch, RG | 1 |
| Timm, KN; Tyler, DJ | 1 |
| Ashabi, G; Nikbakhtzadeh, M; Shaerzadeh, F | 1 |
4 review(s) available for aminoimidazole carboxamide and resveratrol
| Article | Year |
|---|---|
Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Bezafibrate; Disease Models, Animal; Energy Metabolism; Mitochondria; Mitochondrial Diseases; Mitochondrial Turnover; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Ribonucleotides; Sirtuin 1; Stilbenes; Transcription Factors; Up-Regulation | 2014 |
AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
Topics: Aging; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Berberine; Cardiomegaly; Extracellular Matrix Proteins; Fibrosis; Gene Expression Regulation; Humans; Metformin; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Stilbenes; Thiazolidinediones; Wound Healing | 2016 |
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antibiotics, Antineoplastic; Caloric Restriction; Cardiotoxicity; Doxorubicin; Enzyme Activation; Enzyme Activators; Exercise; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondria, Heart; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Thiazolidinediones | 2020 |
Highlighting the Protective or Degenerative Role of AMPK Activators in Dementia Experimental Models.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Dementia; Humans; Models, Theoretical; Neurons; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; TOR Serine-Threonine Kinases | 2021 |
16 other study(ies) available for aminoimidazole carboxamide and resveratrol
| Article | Year |
|---|---|
Resveratrol stimulates AMP kinase activity in neurons.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Brain; Enzyme Activation; Ganglia, Spinal; Male; Mice; Mitochondria; Neurites; Neurons; Neurons, Afferent; Phosphorylation; Protein Serine-Threonine Kinases; Resveratrol; Ribonucleotides; Sirtuin 1; Sirtuins; Stilbenes | 2007 |
AMP-activated protein kinase mediates activity-dependent regulation of peroxisome proliferator-activated receptor gamma coactivator-1alpha and nuclear respiratory factor 1 expression in rat visual cortical neurons.
Topics: Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blindness; Cells, Cultured; Enzyme Activation; Female; Gene Expression Regulation; Male; Membrane Potentials; Mitochondria; Neurons; Nuclear Respiratory Factors; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; Resveratrol; Ribonucleotides; RNA-Binding Proteins; RNA, Messenger; Stilbenes; Transcription Factors; Visual Cortex | 2010 |
Genistein, resveratrol, and 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway.
Topics: Aged; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cells, Cultured; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Induction; Female; Gene Expression Regulation, Enzymologic; Genistein; Hep G2 Cells; Hepatocytes; Humans; Male; Middle Aged; Resveratrol; Ribonucleosides; Signal Transduction; Stilbenes | 2011 |
Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Blotting, Western; Cell Line; Cell Nucleus; Cytoplasm; Enzyme Activators; Fluorescent Antibody Technique; Humans; Microscopy, Confocal; Phenformin; Phosphorylation; Resveratrol; Ribonucleotides; Stilbenes | 2011 |
Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation.
Topics: Administration, Oral; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Inflammation; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Phosphorylation; Resveratrol; Retinitis; Ribonucleotides; Sirtuin 1; Stilbenes; Transcription Factor RelA; Vascular Endothelial Growth Factor A | 2011 |
AMP-activated protein kinase as a promoting factor, but complement and thrombin as limiting factors for acquisition of cytoprotection: implications for induction of accommodation.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; CD55 Antigens; CD59 Antigens; Cell Line; Complement System Proteins; Cytoprotection; Cytotoxicity, Immunologic; Graft Rejection; Humans; Resveratrol; Ribonucleotides; Signal Transduction; Stilbenes; Thrombin; Transplantation Immunology | 2013 |
Defining the action spectrum of potential PGC-1α activators on a mitochondrial and cellular level in vivo.
Topics: Aminoimidazole Carboxamide; Animals; Bezafibrate; HeLa Cells; Humans; Metformin; Mice; Mitochondrial Proteins; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Ribonucleotides; Rosiglitazone; Signal Transduction; Stilbenes; Thiazolidinediones; Transcription Factors | 2014 |
Pharmacological AMP kinase activators target the nucleolar organization and control cell proliferation.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cell Line; Cell Nucleolus; Cell Proliferation; Chromosomal Proteins, Non-Histone; Humans; Nuclear Proteins; Nucleolin; Nucleolus Organizer Region; Nucleophosmin; Phenformin; Phosphoproteins; Resveratrol; Ribonucleotides; Ribosomes; RNA-Binding Proteins; Stilbenes | 2014 |
Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cell Line; Drug Tolerance; Interleukin-1beta; Interleukin-6; Mice; Microglia; Morphine; NF-kappa B; Nitric Oxide Synthase Type II; Nociceptive Pain; p38 Mitogen-Activated Protein Kinases; Resveratrol; Ribonucleotides; Signal Transduction; Stilbenes; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.
Topics: Adipokines; Adipose Tissue; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Aorta; Culture Media, Conditioned; Diet; Fructose; Metformin; NF-kappa B; Palmitic Acid; Rats; Resveratrol; Ribonucleotides; Sirtuin 1; Sodium Salicylate; Stilbenes; Vasodilation | 2014 |
Inhibition of AMPK expression in skeletal muscle by systemic inflammation in COPD rats.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Down-Regulation; Gene Expression Regulation, Enzymologic; Male; Muscle Weakness; Muscle, Skeletal; Pulmonary Disease, Chronic Obstructive; Rats, Wistar; Resveratrol; Ribonucleotides; RNA, Messenger; Sirtuin 1; Stilbenes; Time Factors; Tumor Necrosis Factor-alpha | 2014 |
Resveratrol up-regulates AMPA receptor expression via AMP-activated protein kinase-mediated protein translation.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Cerebral Cortex; Enzyme Inhibitors; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Excitatory Amino Acid Agents; Excitatory Postsynaptic Potentials; Hippocampus; Miniature Postsynaptic Potentials; Neurons; Phosphatidylinositol 3-Kinases; Protein Biosynthesis; Proto-Oncogene Proteins c-akt; Rats; Receptors, AMPA; Resveratrol; Ribonucleotides; Sirtuin 1; Stilbenes; Up-Regulation | 2015 |
Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.
Topics: Adenylate Kinase; Aging; Alzheimer Disease; Aminoimidazole Carboxamide; Animals; Cannabinoids; Enzyme Activation; Gene Deletion; Glycogen Synthase Kinase 3 beta; Hippocampus; Memory; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Phosphorylation; Receptor, Cannabinoid, CB2; Resveratrol; Ribonucleotides; Signal Transduction; tau Proteins | 2018 |
Activation of AMPK in Human Placental Explants Impairs Mitochondrial Function and Cellular Metabolism.
Topics: Adult; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Enzyme Inhibitors; Fatty Acids; Female; Glucose; Humans; Mitochondria; Phosphorylation; Placenta; Pregnancy; Resveratrol; Ribonucleotides; Trophoblasts | 2019 |
Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Animals; Disease Models, Animal; Humans; Mice; Motor Activity; Muscle, Skeletal; Myoblasts; Myotonic Dystrophy; Protein Kinases; Resveratrol; Ribonucleotides; RNA-Binding Proteins; RNA, Messenger; Trinucleotide Repeat Expansion | 2018 |
Five months of voluntary wheel running downregulates skeletal muscle LINE-1 gene expression in rats.
Topics: Aging; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Caffeine; Chromatin; Chromosomal Proteins, Non-Histone; Cyclophilin A; DNA Methylation; Female; Gene Expression Regulation; Hydroxamic Acids; Long Interspersed Nucleotide Elements; Muscle Fibers, Skeletal; Muscle, Skeletal; Physical Conditioning, Animal; Primary Cell Culture; Rats; Rats, Wistar; Resveratrol; Ribonucleotides; RNA, Messenger; Rotenone; Sedentary Behavior | 2019 |